An Exploration of Barriers and Facilitators to Buprenorphine Access via Telehealth

With the guidance of the CHERISH Dissemination & Policy Core Director Zachary Meisel and CHERISH Research Affiliate Laura Starbird, Shoshana Aronowitz will study low-barrier treatments for substance use disorder and expand healthcare services to marginalized populations who use drugs.

Shoshana Aronowitz is a family nurse practitioner, community-engaged health services researcher, and assistant professor in the Department of Family and Community Health at the University of Pennsylvania School of Nursing. Her research examines innovative delivery models to promote equitable access to substance use treatment and harm reduction services, as well as racial disparities in pain management in the context of the opioid overdose crisis. In one of her latest publications, she evaluated a partnership between two community-based organizations and the Philadelphia Department of Public Health that provide free mailed naloxone kits and other harm reduction supplies to Philadelphians. Aronowitz provides opioid use disorder treatment at Prevention Point Philadelphia and Ophelia Health and is a harm reduction community organizer with SOL Collective. She received her undergraduate degree from McGill University and earned her master’s and doctoral degrees from University of Vermont and University of Pennsylvania. She completed her postdoctoral fellowship at the National Clinician Scholars Program University of Pennsylvania site.